Tower Research Capital LLC (Trc) Myriad Genetics Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 28,264 shares of MYGN stock, worth $312,599. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,264
Previous 3,876
629.21%
Holding current value
$312,599
Previous $106,000
265.09%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$168 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$117 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$66.4 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$61.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$48.1 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $892M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...